Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration

被引:0
|
作者
Wei Zhang
Zhao-fen Yan
Jun-hua Gao
Li Sun
Xi-yan Huang
Zhuo Liu
Shu-yang Yu
Chen-Jie Cao
Li-jun Zuo
Ze-Jie Chen
Yang Hu
Fang Wang
Jau-shyong Hong
Xiao-min Wang
机构
[1] Capital Medical University,Department of Neurology, Beijing Tiantan Hospital
[2] Parkinson’s Disease Center of Beijing Institute of Brain Disorders,Neuropharmacology Section, Laboratory of Pharmacology and Chemistry
[3] Beijing Key Laboratory on Parkinson’s Disease,Department of Physiology
[4] National Institute of Environmental Health Sciences/National Institutes of Health,Department of Neurobiology
[5] Capital Medical University,undefined
[6] Capital Medical University,undefined
[7] Key Laboratory for Neurodegenerative Disorders of the Ministry of Education,undefined
[8] Beijing Institute for Brain Disorders,undefined
来源
Molecular Neurobiology | 2014年 / 49卷
关键词
Dopaminergic neurodegeneration; Iron; Microglial activation; Neuroinflammation; β-nicotinamide adenine dinucleotide phosphate oxidase 2; Parkinson’s disease; Mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) patients have excessive iron depositions in substantia nigra (SN). Neuroinflammation characterized by microglial activation is pivotal for dopaminergic neurodegeneration in PD. However, the role and mechanism of microglial activation in iron-induced dopaminergic neurodegeneration in SN remain unclear yet. This study aimed to investigate the role and mechanism of microglial β-nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) activation in iron-induced selective and progressive dopaminergic neurodegeneration. Multiple primary midbrain cultures from rat, NOX2+/+ and NOX2−/− mice were used. Dopaminergic neurons, total neurons, and microglia were visualized by immunostainings. Cell viability was measured by MTT assay. Superoxide (O2·−) and intracellular reactive oxygen species (iROS) were determined by measuring SOD-inhibitable reduction of tetrazolium salt WST-1 and DCFH-DA assay. mRNA and protein were detected by real-time PCR and Western blot. Iron induces selective and progressive dopaminergic neurotoxicity in rat neuron–microglia–astroglia cultures and microglial activation potentiates the neurotoxicity. Activated microglia produce a magnitude of O2·− and iROS, and display morphological alteration. NOX2 inhibitor diphenylene iodonium protects against iron-elicited dopaminergic neurotoxicity through decreasing microglial O2·− generation, and NOX2−/− mice are resistant to the neurotoxicity by reducing microglial O2·− production, indicating that iron-elicited dopaminergic neurotoxicity is dependent of NOX2, a O2·−-generating enzyme. NOX2 activation is indicated by the increased mRNA and protein levels of subunits P47 and gp91. Molecules relevant to NOX2 activation include PKC-σ, P38, ERK1/2, JNK, and NF-КBP65 as their mRNA and protein levels are enhanced by NOX2 activation. Iron causes selective and progressive dopaminergic neurodegeneration, and microglial NOX2 activation potentiates the neurotoxicity. PKC-σ, P38, ERK1/2, JNK, and NF-КBP65 are the potential molecules relevant to microglial NOX2 activation.
引用
收藏
页码:1153 / 1165
页数:12
相关论文
共 50 条
  • [1] Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration
    Zhang, Wei
    Yan, Zhao-fen
    Gao, Jun-hua
    Sun, Li
    Huang, Xi-yan
    Liu, Zhuo
    Yu, Shu-yang
    Cao, Chen-Jie
    Zuo, Li-jun
    Chen, Ze-Jie
    Hu, Yang
    Wang, Fang
    Hong, Jau-shyong
    Wang, Xiao-min
    MOLECULAR NEUROBIOLOGY, 2014, 49 (03) : 1153 - 1165
  • [2] Investigation on the neuroinflammatory mechanism of iron-induced selective dopaminergic neurodegeneration
    Zhang, W.
    Gao, J. -H.
    Yan, Z.
    Liu, Z.
    Sun, L.
    Huang, X.
    Zhang, L.
    Li, B.
    Wang, X.
    Hong, J. -S.
    MOVEMENT DISORDERS, 2011, 26 : S31 - S32
  • [3] Microglial activation is inhibited by corticosterone in dopaminergic neurodegeneration
    Sugama, Shuei
    Takenouchi, Takato
    Kitani, Hiroshi
    Fujita, Masayo
    Hashimoto, Makoto
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 208 (1-2) : 104 - 114
  • [4] Chronic microglial activation and progressive dopaminergic neurotoxicity
    Block, M. L.
    Hong, J. -S.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1127 - 1132
  • [5] A role for iron deficiency in dopaminergic neurodegeneration
    Yien, Yvette Y.
    Paw, Barry H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (13) : 3417 - 3418
  • [6] Microglial activation induced by amyloid-β and prion peptides:: role in neurodegeneration
    Agostinho, P.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 : 12 - 12
  • [7] Tetrahydroxystilbene glucoside protects LPS-induced dopaminergic neurodegeneration via the inhibition of microglial activation
    Zhang, Feng
    Wang, Yan-ying
    Wu, Qin
    Lu, Yuan-fu
    Liu, Jie
    Shi, Jing-shan
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 136 - 137
  • [8] Melatonin suppresses iron-induced neurodegeneration in rat brain
    Lin, AMY
    Ho, LT
    FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (06) : 904 - 911
  • [9] Possible involvement of iron-induced oxidative insults in neurodegeneration
    Asano, Takeshi
    Koike, Masato
    Sakata, Shin-ichi
    Takeda, Yukiko
    Nakagawa, Tomoko
    Hatano, Taku
    Ohashi, Satoshi
    Funayama, Manabu
    Yoshimi, Kenji
    Asanuma, Masato
    Toyokuni, Shinya
    Mochizuki, Hideki
    Uchiyama, Yasuo
    Hattori, Nobutaka
    Iwai, Kazuhiro
    NEUROSCIENCE LETTERS, 2015, 588 : 29 - 35
  • [10] Involvement of exosomes in dopaminergic neurodegeneration by microglial activation in midbrain slice cultures
    Tsutsumi, Reiho
    Hori, Yuria
    Seki, Takahiro
    Kurauchi, Yuki
    Sato, Masahiro
    Oshima, Mutsumi
    Hisatsune, Akinori
    Katsuki, Hiroshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (02) : 427 - 433